Title: REALISTIC: A phase 1 dose escalation of trial of recombinant listeria moncytogenes (lm) based vaccine encoding human papilloma virus serotype 16 target antigens (ADXS11-001) in patients with HPV-16+ oropharyngeal SCC

Cancer Research UK

Principal Investigator

Powell, Ned

Project Details
Net value award figure for Cardiff University: £151,284.00
Start date: 01/10/2010
End date: 30/09/2015

Last updated on 2020-18-09 at 06:01